Groups | the incidence of catastrophic total costs at the threshold | CHE1 | CHE2 |
---|
15% | 20% | 25% |
---|
RS (%) | 43.3 | 33.6 | 26.3 | 39.6 | 56.0 |
RMR (%) | 46.7 | 43.3 | 40.0 | 46.7 | 76.7 |
MDR (%) | 73.2 | 69.6 | 66.1 | 71.4 | 91.1 |
Total (%) | 46.0 | 37.1 | 30.2 | 42.6 | 59.8 |
- Note: RS: rifampicin-susceptible
- RMR rifampicin-monoresistant
- MDR multidrug-resistant
- CHE1: catastrophic health expenditure measured by annual out-of-pocket payments exceeding 40% of the household’s annual capacity to pay during TB treatment
- CHE2: catastrophic health expenditure measured by annual out-of-pocket payments exceeding 10% of the household’s annual income during TB treatment